Pharma exports from region up by over 60%

INDORE: Pharmaceutical exports from the region have registered a growth of over 60 per cent this year as against the previous year led by higher orders and up-gradation in firms.

According to data from Development Commissioner Special Economic Zone (SEZ), exports from pharmaceutical firms in fiscal year 2018/19 stood at Rs 3,771.54 crore, up 67.62 per cent as against Rs 2,249.93 crore in the past year.

An HR executive from a leading pharmaceutical company located in the Special Economic Zone (SEZ) said, “This year was extraordinary for us because the number of orders were high from our customers after we upgraded and passed certain international standards mandatory for exports.”

Pithampur has over 20 pharmaceutical companies and more new companies are expected to set up facilities in the region in coming years as the region has become the hub for pharmaceutical companies.

Another executive from a Pithampur based drug manufacturing unit said, “In comparison to other states, the cost of operations are economical here as companies are getting the SEZ benefits. Electricity is cheap, subsidies are there in addition to other facilities that makes the companies competitive.”

Industrialists said opportunities are huge for pharmaceutical companies in the region as the cost of operations and labour are economical. They expect exports to grow further in the next year.

Industrialists said, the contribution of small-scale drug manufacturers are negligible in exports and to promote them some additional subsidies to help them bear the up-gradation costs should be provided.

Indore has over 120 small scale medicines manufacturing units engaged in production of sanitizers, ointments, syrups and injectable with over 10 units engaged in exports contributing about Rs 500 crore annual exports.

Alok Dave, president, Association of Industries Madhya Pradesh (AIMP) said, “Subsidies and financial assistance will help in increasing exports from small-scale drug manufacturers. The government should also develop a cluster to curtail the cost of operations of small manufacturers.”

  • Related Posts

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Pilibhit: A joint inquiry by the chief medical officer and city magistrate has found alleged statutory violations at several private diagnostic centres and nursing homes in Pilibhit district. A report…

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    According to the ministry, the scheme has facilitated the establishment of domestic manufacturing capabilities for a range of high-end medical devices that were earlier predominantly imported. New Delhi: The Product…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

    MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

    Arogya Manthan 2026 to launch new digital health and health assurance initiatives

    Arogya Manthan 2026 to launch new digital health and health assurance initiatives

    Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

    Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

    Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream

    Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream